This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
EHealth (EHTH) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
eHealth (EHTH) delivered earnings and revenue surprises of 95.00% and 26.29%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
eHealth (EHTH) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
eHealth's (EHTH) first-quarter 2020 results are likely to reflect strong revenues from its Medicare business owing to increased membership.
Earnings Preview: eHealth (EHTH) Q1 Earnings Expected to Decline
by Zacks Equity Research
EHealth (EHTH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why You Should Hold Marsh & McLennan (MMC) in Your Portfolio
by Zacks Equity Research
Banking on strategic acquisitions and financial flexibility, Marsh & McLennan (MMC) holds potential to reap benefits for investors.
Is eHealth (EHTH) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Is (EHTH) Outperforming Other Finance Stocks This Year?
Bullish Near-Term Prospects for Insurance Brokerage Industry
by Sapna Bagaria
Firming up of insurance prices, investment in technology and the ongoing consolidation craze will drive growth for the Insurance Brokerage industry.
5 Top Low-Beta Stocks Surged in March Defying Coronavirus
by Nalak Das
The global financial markets are currently witnessing one of the worst periods since the Great Depression due to the coronavirus-led crisis.
Here's Why Arthur J. Gallagher Stock is an Attractive Bet
by Zacks Equity Research
Arthur J. Gallagher (AJG) remains poised for growth on strategic acquisitions, strong segmental performance and prudent capital deployment, offset by higher expenses.
Zacks.com featured highlights include: eHealth, Franco-Nevada, CBIZ and Garmin
by Zacks Equity Research
Zacks.com featured highlights include: eHealth, Franco-Nevada, CBIZ and Garmin
Is eHealth (EHTH) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Is (EHTH) Outperforming Other Finance Stocks This Year?
4 Momentum Picks Based on Driehaus Strategy
by Nitish Marwah
Richard Herman Driehaus, renowned American businessman and fund manager, created an investment approach using the buy high and sell higher theory.
Brown & Brown's (BRO) Unit Acquires RLA Insurance's Assets
by Zacks Equity Research
Brown & Brown's (BRO) subsidiary acquires assets of RLA Insurance, marking its sixth acquisition in the first quarter of 2020.
Arthur J. Gallagher (AJG) Rides on Strong Brokerage Segment
by Zacks Equity Research
Arthur J. Gallagher (AJG) is poised to benefit from strong segmental performances and a robust capital position.
Willis Towers Gains From Organic Growth & Capital Deployment
by Zacks Equity Research
Willis Towers (WLTW) is poised to benefit from strong organic growth along with solid capital strength.
Top Ranked Momentum Stocks to Buy for March 6th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 6th
Why eHealth (EHTH) Could Be Positioned for a Surge
by Zacks Equity Research
eHealth (EHTH) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.
Will eHealth Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in eHealth.
How eHealth (EHTH) Stock Stands Out in a Strong Industry
by Zacks Equity Research
eHealth (EHTH) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Arthur J. Gallagher (AJG) Acquires Insurance Broker CMS
by Zacks Equity Research
Arthur J. Gallagher (AJG) buys CMS to support its construction and real estate practice and further expand its subsidiary.
Is eHealth (EHTH) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Is (EHTH) Outperforming Other Finance Stocks This Year?
Brown & Brown Up 44% in a Year: Will the Rally Continue?
by Zacks Equity Research
Brown & Brown's (BRO) acquisitions are likely to continue boosting its revenue base, which in turn, might perk up its share price.
Willis Towers Boosts Shareholder Value, Hikes Dividend
by Zacks Equity Research
Willis Towers (WLTW) hikes dividend by 5% in an effort to share more profits with its shareholders.
What's in Store for Willis Towers (WLTW) in Q4 Earnings?
by Zacks Equity Research
Willis Towers' (WLTW) Q4 results are likely to reflect geographic expansion, solid segmental contributions and growth in new business.
Are You Looking for a Top Momentum Pick? Why eHealth (EHTH) is a Great Choice
by Zacks Equity Research
Does eHealth (EHTH) have what it takes to be a top stock pick for momentum investors? Let's find out.
eHealth (EHTH) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
eHealth (EHTH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).